Clinical Trial Update: Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating chemoembolization plus bevacizumab for unresectable liver cancer has completed; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Chemoembolization

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Liver Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-03-15